scholarly journals Evaluating Predictive Value of Preoperative Clinical and Imaging Findings on the Short-Term Outcome of Surgery in Patients Undergoing Lower Lumbar Discectomy

Cureus ◽  
2021 ◽  
Author(s):  
Alireza Tabibkhooei ◽  
Sayyed Ehsan Ziaei ◽  
Maziar Azar ◽  
Meysam Abolmaali
2021 ◽  
Vol 10 ◽  
Author(s):  
Shuai Liang ◽  
Chengming Li ◽  
Zhenhua Gao ◽  
Dongping Shang ◽  
Jinming Yu ◽  
...  

ObjectivesTo investigate the tumor volume and its change on short-term outcome in esophageal squamous cell carcinoma (ESCC) patients who underwent definitive radiotherapy or chemoradiotherapy.Methods and MaterialsAll data were retrospectively collected from 418 ESCC patients who received radiotherapy or chemoradiotherapy at our institution between 2015 and 2019. Short-term outcome using the treatment response evaluation was assessed according to the RECIST 1.1. The tumor volume change rate (TVCR) was defined as follows: TVCR = {1 − [gross tumor volume (GTV) at shrinking irradiation field planning)]/(GTV at the initial treatment planning)} ×100%. Chi square test was used to compare the clinic characteristics in different TVCR groups, and the difference between initial GTV (GTVi) and shrinking GTV (GTVs) was compared using Wilcoxon’s sign rank test. Logistic regression analysis and Spearman correlation was performed.ResultsThere was a significant decrease in GTVi compared to GTVs (P < 0.001). In univariate analysis, age, cT-stage, TNM stage, treatment modality, GTVi, and TVCR were associated with short-term outcome (all P< 0.05). In multivariate analysis, gender and TVCR were statistically significant (P = 0.010, <0.001) with short-term outcome, and the combined predictive value of gender and TVCR exceeded that of TVCR (AUC, 0.876 vs 0.855).ConclusionsTVCR could serve to forecast short-term outcome of radiotherapy or chemoradiotherapy in ESCC. It was of great significance to guide the individualized treatment of ESCC.


2012 ◽  
Vol 33 (5) ◽  
pp. 904-909 ◽  
Author(s):  
K. Johkura ◽  
Y. Nakae ◽  
Y. Kudo ◽  
T.N. Yoshida ◽  
Y. Kuroiwa

2019 ◽  
Vol 2019 ◽  
pp. 1-9
Author(s):  
Zuxiong Huang ◽  
Ning Wang ◽  
Shuiwen Huang ◽  
Yi Chen ◽  
Shida Yang ◽  
...  

Aims. Soluble urokinase plasminogen activator receptor (suPAR) reflects the immune activation in circumstances of inflammation and infection. It has been considered as a risk biomarker associated with poor outcome in various low-grade inflammation and infectious diseases. The study is aimed at investigating whether suPAR has a predictive value with short-term survival in patients with hepatitis B-related acute-on-chronic liver failure (HB-ACLF). Methods. Serum suPAR expression was compared among patients with different states of chronic hepatitis B virus infection. Sixty HB-ACLF patients were recruited as the training cohort and followed up for 90 days. Serum suPAR level and the clinical relevance with short-term outcome were investigated. The temporal dynamics of suPAR were evaluated in 50 HB-ACLF patients with available serum sequentially at baseline, week 2 and week 4. Another 167 HB-ACLF patients were enrolled to validate the predictive value of suPAR with respect to the prognosis. Results. Serum suPAR level was significantly increased in HB-ACLF patients compared to non-ACLF patients. In the training set of HB-ACLF, we observed higher suPAR level, INR, MELD score, and more complications in nonsurvivors than survivors. Longitudinal analysis revealed an increased trend of suPAR level in nonsurvivors during week 0 to week 4 and the modest decline in survivors. It showed that the synchronous suPAR level was higher in nonsurvivors at all indicated time points. Elevated suPAR level at baseline was identified as a strong predictor of a 90-day mortality of HB-ACLF patients. It was confirmed suPAR>16.26 ng/ml had a positive predictive value of 72.22% and a negative predictive value of 77.88% for poor outcome in the validation cohort. Conclusions. Serum suPAR level increases significantly in HB-ACLF patients and associated with a 90-day mortality. It suggests that suPAR might be a potential biomarker to predict the prognosis of HB-ACLF patients.


2021 ◽  
Vol 5 (1) ◽  
pp. 1-2
Author(s):  
Camila Silva Barbosa ◽  
Hye Ju Lee

On October 15th 2020, the Emergency Radiology Journal published our article entitled “COVID-19 pneumonia in the emergency department: correlation of initial chest CT findings with short-term outcome”, that evaluated clinical, laboratorial and imaging findings of laboratory confirmed COVID-19 patients as predictors of severe disease. In this paper, we will explore the context and significance of the early recognition of the disease severity on patients’ management.


2019 ◽  
Vol 5 (2) ◽  
pp. 155-160 ◽  
Author(s):  
Samira Abdel-Wahab Abdel-Aziz ◽  
Mostafa Mohamad Sira ◽  
Emad Hamdy Gad ◽  
Islam Ayoub ◽  
Mervat Soltan

2014 ◽  
Vol 28 (10) ◽  
pp. 1020-1026 ◽  
Author(s):  
Hiroshi Hoshikawa ◽  
Yuka Yamamoto ◽  
Terushige Mori ◽  
Takehito Kishino ◽  
Takashi Fukumura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document